Health
Could synNotch CAR T cells be the answer to fighting solid tumours? – Drug Target Review
Researchers have developed a novel CAR T-cell therapy for neuroblastoma which uses gating to limit toxicity and T-cell exhaustion.
Posted: 22 January 2021 | Hannah Balfour (Drug Target Review) | No comments yet
Researchers have developed a novel CAR T-cell therapy for neuroblastoma which uses gating to limit toxicity and T-cell exhaustion.
A novel chimeric antigen receptor T-cell (CAR T) therapy targeting neuroblastoma effectively killed cancer cells while sparing healthy tissues in pre-clinical studies. While this work is in the preclinical phase, the developers of the treatment said it opens the door for other potentially…
-
Noosa News16 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast
-
General17 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle
-
Business22 hours agoDown 20% this year, here are 3 reasons why I’m still loading up on Amazon stock
-
General22 hours agoStocks, dollar sink as trade war roils markets